1. Home
  2. NVCR vs ESBA Comparison

NVCR vs ESBA Comparison

Compare NVCR & ESBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • ESBA
  • Stock Information
  • Founded
  • NVCR 2000
  • ESBA N/A
  • Country
  • NVCR Switzerland
  • ESBA United States
  • Employees
  • NVCR N/A
  • ESBA N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • ESBA
  • Sector
  • NVCR Health Care
  • ESBA
  • Exchange
  • NVCR Nasdaq
  • ESBA NYSE
  • Market Cap
  • NVCR 1.9B
  • ESBA 2.0B
  • IPO Year
  • NVCR 2015
  • ESBA 2013
  • Fundamental
  • Price
  • NVCR $17.44
  • ESBA $7.11
  • Analyst Decision
  • NVCR Buy
  • ESBA
  • Analyst Count
  • NVCR 6
  • ESBA 0
  • Target Price
  • NVCR $32.83
  • ESBA N/A
  • AVG Volume (30 Days)
  • NVCR 861.0K
  • ESBA 6.5K
  • Earning Date
  • NVCR 04-24-2025
  • ESBA 01-01-0001
  • Dividend Yield
  • NVCR N/A
  • ESBA 1.90%
  • EPS Growth
  • NVCR N/A
  • ESBA N/A
  • EPS
  • NVCR N/A
  • ESBA 0.30
  • Revenue
  • NVCR $621,711,000.00
  • ESBA $762,039,000.00
  • Revenue This Year
  • NVCR $2.90
  • ESBA N/A
  • Revenue Next Year
  • NVCR $10.47
  • ESBA N/A
  • P/E Ratio
  • NVCR N/A
  • ESBA $23.49
  • Revenue Growth
  • NVCR 18.27
  • ESBA 3.19
  • 52 Week Low
  • NVCR $14.17
  • ESBA $6.39
  • 52 Week High
  • NVCR $34.13
  • ESBA $11.50
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 48.61
  • ESBA 48.73
  • Support Level
  • NVCR $16.19
  • ESBA $7.00
  • Resistance Level
  • NVCR $18.52
  • ESBA $7.47
  • Average True Range (ATR)
  • NVCR 0.85
  • ESBA 0.19
  • MACD
  • NVCR 0.06
  • ESBA 0.07
  • Stochastic Oscillator
  • NVCR 54.82
  • ESBA 64.05

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About ESBA EMPIRE STATE REALTY OP LIM PARTNER

Empire State Realty OP LP is an NYC-focused real estate investment trust (REIT) that owns and operates a portfolio of well-leased, top-of-tier, modernized, amenitized, and well-located office, retail, and multifamily assets, conducts all of its business and owns substantially all of its assets. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.

Share on Social Networks: